Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Cochin Shipyard Ltd / Equity Capital Markets

<p>Cochin Shipyard, the largest state-owned shipyard in India, is looking to raise US$225m to fund its expansion plan. In this insight, we will look at fundamentals of its business, industry backdrop, valuation and score the deal in our ECM framework.</p>

Cochin Shipyard, the largest state-owned shipyard in India, is looking to raise US$225m to fund its expansion plan. In this insight, we will look at fundamentals of its business, industry backdrop, valuation and score the deal in our ECM framework.

Cochin Shipyard IPO: Defence Contracts Make It Defensive

APAC IPOs & Placements

Zhen Zhou, Toh

<p><em>The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.</em></p><div class="content-highlight"><p><a href="https://www.smartkarma.com/entities/23641" target="_blank" data-smartkarma-citation="entities:23641:1">Celltrion Healthcare (091990 KS)</a> made a fantastic debut on Friday, rising 22% above deal price. However, investors should be cognizant about its expensive valuation at current price level, citing <a href="https://www.smartkarma.com/profiles/354" target="_blank" data-smartkarma-citation="accounts:354">Sanghyun Park</a>'s concern about a potential bubble in his insights. <a href="https://www.smartkarma.com/profiles/13" target="_blank" data-smartkarma-citation="accounts:13">Kemp Dolliver, CFA</a> also brought up concerns earlier in April about celltrion's biosimilar, Remicade, which had…</p></div>

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Celltrion Healthcare (091990 KS) made a fantastic debut on Friday, rising 22% above deal price. However, investors should be cognizant about its expensive valuation at current price level, citing Sanghyun Park's concern about a potential bubble in his insights. Kemp Dolliver, CFA also brought up concerns earlier in April about celltrion's biosimilar, Remicade, which had…

Smartkarma: ECM Coverage Weekly Update (29 July 2017)

India

Cochin Shipyard Limited operates as a marine building company. The Company offers ship-building, ship repair, offshore, and testing services. Cochin Shipyard serves customers worldwide.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Cochin Shipyard Ltd (COCHIN IN)

Cochin Shipyard IPO: Defence Contracts Make It Defensive

Cochin Shipyard, the largest state-owned shipyard in India, is looking to raise US$225m to fund its expansion plan. In this insight, we will look...

Ke Yan, CFA, FRM

Smartkarma: ECM Coverage Weekly Update (29 July 2017)

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. Celltrion Healthcare...

Zhen Zhou, Toh

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)